These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 26156869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein.
    Sjögren J, Struwe WB, Cosgrave EF, Rudd PM, Stervander M, Allhorn M, Hollands A, Nizet V, Collin M.
    Biochem J; 2013 Oct 01; 455(1):107-18. PubMed ID: 23865566
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.
    Allhorn M, Olsén A, Collin M.
    BMC Microbiol; 2008 Jan 08; 8():3. PubMed ID: 18182097
    [Abstract] [Full Text] [Related]

  • 6. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
    Huang W, Giddens J, Fan SQ, Toonstra C, Wang LX.
    J Am Chem Soc; 2012 Jul 25; 134(29):12308-18. PubMed ID: 22747414
    [Abstract] [Full Text] [Related]

  • 7. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D, Haberger M, Falck D, Peter B, Maier B, Gassner J, Hook M, Wagner K, Bonnington L, Bulau P, Wuhrer M.
    MAbs; 2015 Jul 25; 7(4):732-42. PubMed ID: 25996192
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies.
    Trastoy B, Lomino JV, Pierce BG, Carter LG, Günther S, Giddens JP, Snyder GA, Weiss TM, Weng Z, Wang LX, Sundberg EJ.
    Proc Natl Acad Sci U S A; 2014 May 06; 111(18):6714-9. PubMed ID: 24753590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S.
    Trastoy B, Klontz E, Orwenyo J, Marina A, Wang LX, Sundberg EJ, Guerin ME.
    Nat Commun; 2018 May 14; 9(1):1874. PubMed ID: 29760474
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of antibody-specific deglycosylation and immune evasion by Streptococcal IgG-specific endoglycosidases.
    Trastoy B, Du JJ, Cifuente JO, Rudolph L, García-Alija M, Klontz EH, Deredge D, Sultana N, Huynh CG, Flowers MW, Li C, Sastre DE, Wang LX, Corzana F, Mallagaray A, Sundberg EJ, Guerin ME.
    Nat Commun; 2023 Mar 27; 14(1):1705. PubMed ID: 36973249
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
    Reusch D, Haberger M, Maier B, Maier M, Kloseck R, Zimmermann B, Hook M, Szabo Z, Tep S, Wegstein J, Alt N, Bulau P, Wuhrer M.
    MAbs; 2015 Mar 27; 7(1):167-79. PubMed ID: 25524468
    [Abstract] [Full Text] [Related]

  • 20. Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody.
    Giddens JP, Lomino JV, DiLillo DJ, Ravetch JV, Wang LX.
    Proc Natl Acad Sci U S A; 2018 Nov 20; 115(47):12023-12027. PubMed ID: 30397147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.